Most of the clinical manifestations of CRS are the consequence of endothelial cell activation and damage by circulating cytokines; IL-6, acting through its soluble receptors, seems to have a dominant role in this process [17]. The gene discussed is IL6; the disease is congenital rubella syndrome.